当前位置： SCI文献检索 > Molecular Genetics & Genomic Medicine期刊下所有文献 > Clinical implementation of gene panel testing for lysosomal storage diseases.

Clinical implementation of gene panel testing for lysosomal storage diseases.

Abstract：

BACKGROUND:The diagnostic workup in patients with a clinical suspicion of lysosomal storage diseases (LSD) is often difficult due to the variability in the clinical phenotype. The gold standard for diagnosis of LSDs consists of enzymatic testing. However, due to the sequential nature of this methodology and inconsistent genotype-phenotype correlations of certain LSDs, finding a diagnosis can be challenging. METHOD:We developed and clinically implemented a gene panel covering 50 genes known to cause LSDs when mutated. Over a period of 18 months, we analyzed 150 patients who were referred for LSD testing and compared these results with the data of patients who were previously enrolled in a scheme of classical biochemical testing. RESULTS:Our panel was able to determine the molecular cause of the disease in 22 cases (15%), representing an increase in diagnostic yield compared to biochemical tests developed for 21 LSDs (4.6%). We were furthermore able to redirect the diagnosis of a mucolipidosis patient who was initially suspected to be affected with galactosialidosis. Several patients were identified as being affected with neuronal ceroid lipofuscinosis, which cannot readily be detected by enzyme testing. Finally, several carriers of pathogenic mutations in LSD genes related to the disease phenotype were identified as well, thus potentially increasing the diagnostic yield of the panel as heterozygous deletions cannot be detected. CONCLUSION:We show that the implementation of a gene panel for LSD diagnostics results in an increased yield in comparison to classical biochemical testing. As the panel is able to cover a wider range of diseases, we propose to implement this methodology as a first-tier test in cases of an aspecific LSD presentation, while enzymatic testing remains the first choice in patients with a more distinctive clinical presentation. Positive panel results should however still be enzymatically confirmed whenever possible.

journal_name

Mol Genet Genomic Med

journal_title

Molecular genetics & genomic medicine

authors

Gheldof A,Seneca S,Stouffs K,Lissens W,Jansen A,Laeremans H,Verloo P,Schoonjans AS,Meuwissen M,Barca D,Martens G,De Meirleir L

doi

10.1002/mgg3.527

subject

Has Abstract

pub_date

2019-02-01 00:00:00

pages

e00527

issue

issn

2324-9269

journal_volume

pub_type

杂志文章

在线工具

Clinical implementation of gene panel testing for lysosomal storage diseases.